Company Search:
Advanced Search
Sponsored Links
Kancera AB Company Snapshot
Kancera AB operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other pharmaceutical manufacturers in Europe: Index Pharmaceuticals Holding Ab (2016 sales of 176,000.00 Swedish Kronor [US$21,868.00 ] ), MPH Health Care AG of Germany (47,325.96 Euro [US$56,139.95 ] ), and Infant Bacterial Therapeutics AB (162,000.00 Swedish Kronor [US$20,128.50 ] ).

Sales Analysis. Kancera AB reported sales of SEK 308,000.00 (US$38.27 thousand) for the year ending December of 2016. This represents an increase of 9.2% versus 2015, when the company's sales were SEK 282,000.00 . Despite this increase, sales are still well below the level achieved in 2014, when Kancera AB reported sales of SEK 470,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kancera AB
  Stock Performance Chart for Kancera AB
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 2.55
(Figures in Swedish Kronor)
1 Week -1.9%   13 Weeks 16.4%  
4 Weeks -2.3%   52 Weeks -17.6%  
Kancera AB Key Data:
  Ticker: KAN Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 308,000
(Year Ending Jan 2017).
Employees: 13
  Currency: Swedish Kronor Market Cap: 346,617,200
  Fiscal Yr Ends: December Shares Outstanding: 135,928,314
  Share Type: AKTIER Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.